633 related articles for article (PubMed ID: 18377612)
21. Photodynamic therapy: An option in mycosis fungoides.
Pileri A; Sgubbi P; Agostinelli C; Infusino SD; Vaccari S; Patrizi A
Photodiagnosis Photodyn Ther; 2017 Dec; 20():107-110. PubMed ID: 28890210
[TBL] [Abstract][Full Text] [Related]
22. Investigation of the use of the pulsed dye laser in the treatment of Bowen's disease using 5-aminolaevulinic acid phototherapy.
Britton JE; Goulden V; Stables G; Stringer M; Sheehan-Dare R
Br J Dermatol; 2005 Oct; 153(4):780-4. PubMed ID: 16181460
[TBL] [Abstract][Full Text] [Related]
23. Successful treatment of oral verrucous hyperplasia and oral leukoplakia with topical 5-aminolevulinic acid-mediated photodynamic therapy.
Chen HM; Yu CH; Tu PC; Yeh CY; Tsai T; Chiang CP
Lasers Surg Med; 2005 Aug; 37(2):114-22. PubMed ID: 16037967
[TBL] [Abstract][Full Text] [Related]
24. Treatment of mycosis fungoides using a 308-nm excimer laser: two case studies.
Meisenheimer JL
Dermatol Online J; 2006 Dec; 12(7):11. PubMed ID: 17459297
[TBL] [Abstract][Full Text] [Related]
25. Narrowband UVB phototherapy for early-stage mycosis fungoides: evaluation of clinical and histopathological changes.
Gökdemir G; Barutcuoglu B; Sakiz D; Köşlü A
J Eur Acad Dermatol Venereol; 2006 Aug; 20(7):804-9. PubMed ID: 16898902
[TBL] [Abstract][Full Text] [Related]
26. Photodynamic therapy as an alternative treatment for mycosis fungoides: a systemic review and meta-analysis.
Seyed Jafari SM; Cazzaniga S; Hunger RE
G Ital Dermatol Venereol; 2018 Dec; 153(6):827-832. PubMed ID: 29683282
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of photodynamic therapy of skin cancers with partial differential alpha-aminolevulinic acid.
Xu S; Wang X; Xu W; Xia Y; Zhang C
Chin Med J (Engl); 2002 Aug; 115(8):1141-5. PubMed ID: 12215278
[TBL] [Abstract][Full Text] [Related]
28. 5-Aminolevulinic acid-mediated photodynamic therapy to superficial malignant skin tumors using Super Lizer.
Hirata Y; Koga S; Fukui N; Yu A; Koshida S; Kosaka Y; Kurokawa T; Moriwaki S
J Dermatol; 2011 Aug; 38(8):748-54. PubMed ID: 21352331
[TBL] [Abstract][Full Text] [Related]
29. Successful treatment of an extensive verrucous carcinoma with topical 5-aminolevulinic acid-mediated photodynamic therapy.
Chen HM; Chen CT; Yang H; Lee MI; Kuo MY; Kuo YS; Wang YP; Tsai T; Chiang CP
J Oral Pathol Med; 2005 Apr; 34(4):253-6. PubMed ID: 15752262
[TBL] [Abstract][Full Text] [Related]
30. Unilesional follicular mycosis fungoides: report of two cases with progression to tumor stage and review of the literature.
Kempf W; Kazakov DV; Schermesser M; Buechner SA; Parmentier L; Wysocki A; Palmedo G; Häusermann P
J Cutan Pathol; 2012 Sep; 39(9):853-60. PubMed ID: 22882174
[TBL] [Abstract][Full Text] [Related]
31. Photodynamic therapy and plaque phase mycosis fungoides.
Fernández-Guarino M; Jaén P
G Ital Dermatol Venereol; 2011 Dec; 146(6):457-61. PubMed ID: 22095177
[TBL] [Abstract][Full Text] [Related]
32. Aminolevulinic acid photodynamic therapy for skin cancers.
Blume JE; Oseroff AR
Dermatol Clin; 2007 Jan; 25(1):5-14. PubMed ID: 17126737
[TBL] [Abstract][Full Text] [Related]
33. Successful treatment of lymphadenosis benigna cutis with topical photodynamic therapy with delta-aminolevulinic acid.
Takeda H; Kaneko T; Harada K; Matsuzaki Y; Nakano H; Hanada K
Dermatology; 2005; 211(3):264-6. PubMed ID: 16205072
[TBL] [Abstract][Full Text] [Related]
34. Comparative study of photodynamic therapy vs CO2 laser vaporization in treatment of condylomata acuminata: a randomized clinical trial.
Chen K; Chang BZ; Ju M; Zhang XH; Gu H
Br J Dermatol; 2007 Mar; 156(3):516-20. PubMed ID: 17300242
[TBL] [Abstract][Full Text] [Related]
35. Photodynamic therapy using direct-current pulsed iontophoresis for 5-aminolevulinic acid application.
Mizutani K; Watanabe D; Akita Y; Akimoto M; Tamada Y; Matsumoto Y
Photodermatol Photoimmunol Photomed; 2009 Oct; 25(5):280-2. PubMed ID: 19747250
[TBL] [Abstract][Full Text] [Related]
36. Laser-mediated photodynamic therapy of actinic cheilitis.
Alexiades-Armenakas MR; Geronemus RG
J Drugs Dermatol; 2004; 3(5):548-51. PubMed ID: 15552607
[TBL] [Abstract][Full Text] [Related]
37. The effect of psoralen plus ultraviolet A in vitro in HUT-78 enhances by 5-aminolevulinic acid.
Akita Y; Watanabe D; Yanagishita T; Kuhara T; Kawamura C; Masuda Y; Kawada M; Nakaseko H; Tamada Y; Matsumoto Y
Photodermatol Photoimmunol Photomed; 2007; 23(2-3):95-7. PubMed ID: 17523931
[TBL] [Abstract][Full Text] [Related]
38. Clinical investigation of the novel iron-chelating agent, CP94, to enhance topical photodynamic therapy of nodular basal cell carcinoma.
Campbell SM; Morton CA; Alyahya R; Horton S; Pye A; Curnow A
Br J Dermatol; 2008 Aug; 159(2):387-93. PubMed ID: 18544077
[TBL] [Abstract][Full Text] [Related]
39. Comparison of sensitivity towards photodynamic therapy of cutaneous resident and infiltrating cell types in vitro.
Boehncke WH; Rück A; Naumann J; Sterry W; Kaufmann R
Lasers Surg Med; 1996; 19(4):451-7. PubMed ID: 8983006
[TBL] [Abstract][Full Text] [Related]
40. Current treatments of actinic keratosis.
Gold MH; Nestor MS
J Drugs Dermatol; 2006 Feb; 5(2 Suppl):17-25. PubMed ID: 16485877
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]